Transforming high-content screening with intelligent imaging and AI analysis

June 26, 2025 at 16:00 BST / 17:00 CEST / 11:00 EDT / 08:00 PDT

High-content imaging is essential in drug discovery, but as assays grow more complex, researchers need faster, more powerful imaging and analysis tools to extract high-quality data efficiently.

Register for this exclusive webinar to hear from two Molecular Devices experts, Dr. Angeline Lim and Dr. Andy Bashford, as they share real-world applications, including phenotypic profiling and patient-derived organoid imaging, using a next-generation high-content screening system - ImageXpress^® HCS.ai.

Discover how this platform can elevate your screening and image capturing with its enhanced imaging quality and AI-powered analysis, to improve assay reproducibility, produce deeper insights and take your screening to the next level.

Key learning objectives

• Master essential high-content imaging assays from 2D phenotypic profiling to 3D imaging using patient-derived organoids
• Discover the latest innovations in the ImageXpress HCS.ai platform and how it enhances speed, quality, and flexibility
• Explore the power of AI-driven analysis with IN Carta software to tackle the most challenging screening assays

Who should attend?

• Scientists, directors, managers and imaging specialists working in biotech, pharma and academic sectors.

Certificate of attendance
If you attend the live webinar, you will automatically receive a certificate of attendance, including a learning outcomes summary, for continuing education purposes.

If you view the on-demand webinar, you can request a certificate of attendance by emailing editor@selectscience.net.